scispace - formally typeset
R

Renée F A G de Bruijn

Researcher at Erasmus University Medical Center

Publications -  7
Citations -  710

Renée F A G de Bruijn is an academic researcher from Erasmus University Medical Center. The author has contributed to research in topics: Cognitive decline & Rotterdam Study. The author has an hindex of 6, co-authored 7 publications receiving 620 citations. Previous affiliations of Renée F A G de Bruijn include Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Common variants at 12q14 and 12q24 are associated with hippocampal volume

Joshua C. Bis, +96 more
- 15 Apr 2012 - 
TL;DR: In this article, a genome-wide association study (GWAS) of dementia-free persons (n = 9,232) identified 46 SNPs at four loci with P values of <4.0 × 10(-7).
Journal ArticleDOI

The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study

TL;DR: Although prevention and treatment options of cardiovascular risk factors and diseases have improved, the preventive potential for dementia has not declined over the last two decades.
Journal ArticleDOI

Adiposity as a cause of cardiovascular disease: a Mendelian randomization study

Sara Hägg, +68 more
TL;DR: In this paper, the effect of body mass index (BMI) on risk of cardiovascular diseases was investigated using Mendelian randomization (MR) methods, and the results indicated a strong association between BMI and incident coronary heart disease (CHD), heart failure, and ischaemic stroke.
Journal ArticleDOI

Determinants, MRI Correlates, and Prognosis of Mild Cognitive Impairment: The Rotterdam Study

TL;DR: It was found that several vascular risk factors and MRI-correlates of cerebrovascular disease were related to MCI in the general population and participants with MCI had an increased risk of dementia, including Alzheimer's disease, and mortality.

Featured Article Trajectories of decline in cognition and daily functioning in preclinical dementia

TL;DR: Investigation of trajectories of cognition and daily functioning in preclinical dementia, during 18 years of follow‐up, finds clear trends in decline in cognition and day-to-day functioning.